相关实验视频

Updated: Jan 7, 2026

Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease

Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease

Published on: January 7, 2014

在一氧化碳中毒后延迟发病的帕金森症:从病例报告中的神经心理学观点

Michelle Ingiardi^1,2, Elisa Pini¹, Veronica Laini¹

¹Neurology Operating Unit, Fondazione Poliambulanza Istituto Ospedaliero, Brescia, Italy.

|December 29, 2025

概括

在一氧化碳中毒 (COP) 后延迟的帕金森症和认知缺陷在联合治疗中得到改善. 在这种情况下,神经心理康复与医疗治疗一起有助于功能恢复.

科学领域:

神经学神经学
毒理学毒理学毒理学
康复医学康复医学康复医学

背景情况:

一氧化碳中毒 (COP) 可以导致神经系统的延迟,包括帕金森症和认知缺陷.
这些延迟的效应可能在无症状间隔后表现出来,显著影响日常功能.
了解COP的长期后果对于有效的患者管理至关重要.

研究的目的:

介绍COP后患有迟发帕金森症和认知缺陷的患者的临床演变.
评估一种综合治疗方法的疗效,包括药物治疗,高压氧气疗法 (HBOT) 和神经心理康复.
突出个性化干预在管理神经延迟后续的作用.

主要方法:

一份病例报告,详细说明COP后患者的临床过程.
实施多模式治疗策略:药物治疗,HBOT周期和定制的神经心理康复.
对神经和认知功能进行纵向评估.

主要成果:

患者在COP后大约一个月出现了延迟的帕金森症和认知障碍.
综合治疗方法导致了逐渐的功能改善.
在持续的注意力,记忆力和执行功能方面,尽管存在残余缺陷,但观察到显著的收益.

结论:

在COP后延迟的神经后续,包括帕金森症和认知缺陷,可以有效地管理.
结合医疗干预和个性化神经心理康复的综合治疗策略是有益的.
神经心理康复在促进COP相关神经障碍患者的功能恢复方面发挥着至关重要的作用.

关键词:

一氧化碳中毒是一氧化碳中毒延迟的神经系统的后续.神经心理评估神经心理评估神经心理康复疗法神经心理康复疗法帕金森主义是帕金森主义.

更多相关视频

Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease

Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease

Published on: October 4, 2021

相关概念视频

Parkinson's Disease: Treatment

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...

Parkinson's Disease: Overview

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...

Anticholinesterase Agents: Poisoning and Treatment

Anticholinesterase Agents: Poisoning and Treatment

Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...

Disorders of the Nervous Tissue

Disorders of the Nervous Tissue

Nervous tissue is a vital component of the human body's communication system, enabling us to perceive and respond to stimuli. However, like all other tissues, it is vulnerable to disorders and diseases that can significantly impact our neurological functioning.
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...

COPD: Pathogenesis and Clinical Features

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...

Acute Respiratory Failure-III

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...